Resources · Guides
Sleep study billing guide (2026)
Sleep medicine billing sits at the intersection of prior authorization, site-of-service rules, and therapy compliance documentation — which is why practices that bill it casually leak revenue for months without noticing. This guide covers the study types, the authorization pathways, and the component billing that trips up reading physicians.
Educational guide, not compliance advice. Verify codes and coverage against current AMA CPT, CMS policy, and your payer's medical policy before billing — home-sleep-test codes and Medicare coverage rules in particular change and vary by plan.
Study types and codes
In-lab (attended) studies. Polysomnography (95810) and PSG with CPAP/BiPAP titration (95811) are the attended-lab core. Time and parameter requirements apply.
Home sleep tests (HST). Unattended studies bill under their own code family, and Medicare uses distinct codes for HST. Coverage criteria differ meaningfully between Medicare and commercial plans, so confirm the current code and coverage rule per plan before billing rather than assuming.
Split-night studies. A diagnostic PSG converting to titration in a single night has payer-specific billing rules; check the payer's policy for how the split night should be reported.
The authorization pathway problem
Most commercial plans gate in-lab studies behind prior authorization, and many require a home sleep test first — an in-lab study is only authorized after a failed, inconclusive, or clinically inappropriate HST. Scheduling an in-lab study without confirming the payer's sequence is the most expensive scheduling mistake in sleep medicine: the study happens, the claim dies, and the appeal usually loses because the pathway rule was published all along.
Practical rule: confirm the payer's diagnostic sequence per plan, not per payer — plans within one insurer can differ.
Who bills what: global, professional, technical
Sleep labs and reading physicians routinely get component billing wrong in both directions. If your physician reads studies for a lab they don't own, the physician bills the professional component with modifier 26 and the lab bills the technical component. If the practice owns the lab, it may bill global. When both parties accidentally bill global — or both bill components that overlap — payers see duplicates and deny both. Paper the arrangement explicitly and set standing billing rules per site.
CPAP compliance is a billing problem wearing a clinical costume
Coverage for positive airway pressure therapy and resupply depends on documented usage compliance and timely follow-up evaluation, especially under Medicare rules. Miss the compliance documentation window and downstream claims — device, supplies, follow-up — begin failing quietly. Someone has to own that calendar — ask any biller you evaluate who would.
Frequently asked questions
What CPT code is an overnight sleep study?
Attended in-lab polysomnography bills 95810; when CPAP titration is performed the same night, 95811 applies. Home sleep tests bill under a different code family with their own coverage rules.
Do sleep studies require prior authorization?
For in-lab studies under most commercial plans, yes — and many plans require a home sleep test first. Home tests are gated less often. The sequence is plan-specific; confirm before scheduling.
Why were our sleep study reads denied as duplicates?
Almost always component overlap: the reading physician and the lab both billed global, or overlapping components. The fix is a papered arrangement with standing modifier-26 rules for the reading side.